Early immunotherapy shows strong responses in advanced basal cell carcinoma
Johns Hopkins Medicine - 18-Nov-2025First-line nivolumab doubles typical response rates in inoperable basal cell carcinoma
Johns Hopkins Kimmel Cancer Center is a world-leading institution advancing cancer research
The Johns Hopkins Kimmel Cancer Center is a world-renowned institution dedicated to cancer research, treatment, and education. Based at Johns Hopkins Medicine in Baltimore, Maryland, the center has earned a reputation as a leader in oncology for its groundbreaking research, comprehensive patient care, and commitment to translating scientific discoveries into real-world therapies.
Named after philanthropist Sidney Kimmel, who made a transformative donation to the center, the Kimmel Cancer Center is one of only a few cancer centers in the United States designated as a Comprehensive Cancer Center by the National Cancer Institute. This designation reflects the center’s excellence across laboratory research, clinical trials, population science, and education.
Visit website: https://www.hopkinsmedicine.org/kimmel-cancer-center
Details last updated 05-May-2025
First-line nivolumab doubles typical response rates in inoperable basal cell carcinoma
A new liquid biopsy developed at Johns Hopkins uses machine learning to spot brain tumours